Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate”

Detalles Bibliográficos
Autores principales: Cahn, Rachel Tallman, Zinn, Zachary, Kolodney, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912810/
https://www.ncbi.nlm.nih.gov/pubmed/36773822
http://dx.doi.org/10.1016/j.jaad.2023.02.002
_version_ 1784885284311138304
author Cahn, Rachel Tallman
Zinn, Zachary
Kolodney, Michael S.
author_facet Cahn, Rachel Tallman
Zinn, Zachary
Kolodney, Michael S.
author_sort Cahn, Rachel Tallman
collection PubMed
description
format Online
Article
Text
id pubmed-9912810
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher by the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-99128102023-02-13 Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate” Cahn, Rachel Tallman Zinn, Zachary Kolodney, Michael S. J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2023-06 2023-02-10 /pmc/articles/PMC9912810/ /pubmed/36773822 http://dx.doi.org/10.1016/j.jaad.2023.02.002 Text en © 2023 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Cahn, Rachel Tallman
Zinn, Zachary
Kolodney, Michael S.
Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate”
title Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate”
title_full Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate”
title_fullStr Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate”
title_full_unstemmed Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate”
title_short Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate”
title_sort tumor necrosis factor inhibitors and methotrexate are associated with decreased covid-19-related hospitalization: follow up of “clinical outcomes of covid-19 in patients taking tumor necrosis factor inhibitors and methotrexate”
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912810/
https://www.ncbi.nlm.nih.gov/pubmed/36773822
http://dx.doi.org/10.1016/j.jaad.2023.02.002
work_keys_str_mv AT cahnracheltallman tumornecrosisfactorinhibitorsandmethotrexateareassociatedwithdecreasedcovid19relatedhospitalizationfollowupofclinicaloutcomesofcovid19inpatientstakingtumornecrosisfactorinhibitorsandmethotrexate
AT zinnzachary tumornecrosisfactorinhibitorsandmethotrexateareassociatedwithdecreasedcovid19relatedhospitalizationfollowupofclinicaloutcomesofcovid19inpatientstakingtumornecrosisfactorinhibitorsandmethotrexate
AT kolodneymichaels tumornecrosisfactorinhibitorsandmethotrexateareassociatedwithdecreasedcovid19relatedhospitalizationfollowupofclinicaloutcomesofcovid19inpatientstakingtumornecrosisfactorinhibitorsandmethotrexate

Ejemplares similares